EcoDrugPlus

Androgen Receptor-Like

Ensembl ID : ENSMAMG00000013798
Gene Symbol: LOC113144159
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSMAMG00000002624
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSMAMG00000023156
Gene Symbol: APLNR2
2 Cross references
171 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSMAMG00000000284
Gene Symbol: ALOX12
2 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSMAMG00000000596
Gene Symbol: ALOX5A
3 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSMAMG00000015126
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arg8-Vasotocin Receptor-Like

Ensembl ID : ENSMAMG00000019423
Gene Symbol: LOC113141968
2 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1aa

Ensembl ID : ENSMAMG00000023133
Gene Symbol: AVPR1AA
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMAMG00000005420
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Aromatase

Ensembl ID : ENSMAMG00000011245
Gene Symbol: LOC113137940
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSMAMG00000018353
Gene Symbol: LOC113136491
2 Cross references
191 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSMAMG00000022211
Gene Symbol: LOC113125870
3 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).